Applications submitted to the FY17 research program must address at least one of the seven Areas of Emphasis listed below:
The FDA Oncology Center of Excellence has begun a podcast series called “Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)” about new product approvals, emerging safety information for cancer treatments, and other topics in cancer drug development.
FDA granted regular approval to Keytruda (pembrolizumab) for patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy or within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
The Committee for Medicinal Products for Human Use of the European Medicines Agency recommended approval of expanding the use of Zykadia (ceritinib) to include the first-line treatment of patients with advanced non-small cell lung cancer whose tumors are anaplastic lymphoma kinase-positive.
Peter BoyleTessa HolyoakePeter Boyle, president of the International Prevention Research Institute and director, of the University of Strathclyde Institute of Global Public Health and Tessa Holyoake, director of the Paul O'Gorman Leukaemia Research Centre, Gartnavel General Hospital, Glasgow, received this year's RSE Royal Medals.
Richard Peto will receive the William L. McGuire Memorial Lecture Award at the 2017 San Antonio Breast Cancer Symposium held Dec. 5-9. The McGuire Award was established in 1992 to honor William McGuire, who, along with Charles Coltman, founded SABCS in 1978. The topic of Peto’s award lecture will be announced at a later date.... […]
Winship Cancer Institute of Emory University earned the comprehensive cancer center designation.Effective immediately, Winship becomes the newest NCI-designated comprehensive cancer center in the nation. The number of comprehensive cancer centers now goes up to 48. There are also 14 clinical centers and seven basic research centers.Winship Cancer Institute of Emory University earned the comprehensive cancer center designation.
Steering clear of metaphors that stem from military campaigns and space travel, St. Jude Children's Research Hospital is planning to spend $7 billion over six years for an expansion of clinical and research programs.
James Downing was named recipient of the Society of the Society of Memorial Sloan Kettering Prize. The award, created in 2016, recognizes an individual who has made exceptional and significant contributions to the field of pediatric oncology. Richard O’Reilly, chief, Pediatric Bone Marrow Transplant Service at MSK and the Claire L. Tow Chair in Pediatric... […]
Stephan Grupp will become chief of the Section of Cellular Therapy and Transplant in the Children’s Hospital of Philadelphia Division of Oncology. Grupp, who has researched and led groundbreaking clinical trials of an innovative T cell therapy for children with acute lymphoblastic leukemia, will assume this position on June 1. He joined the University of... […]
